Human-induced pluripotent stem cell overexpressing tlx and use thereof
AssigneePanexo Biotech SG PTE. LTD
InventorsYi WANG, Haifeng SONG, Mingzhi XU, Gang CHEN, Yanan DONG, Miaomiao XUE, Danfeng WANG
Life of this patent
Estimating the term…
Loading patent…
AssigneePanexo Biotech SG PTE. LTD
InventorsYi WANG, Haifeng SONG, Mingzhi XU, Gang CHEN, Yanan DONG, Miaomiao XUE, Danfeng WANG
Estimating the term…
Provided are a human-induced pluripotent stem cell overexpressing TLX and use thereof. By enabling a human-induced pluripotent stem cell (hiPSC) to overexpress TLX or a truncation thereof, the self-driven differentiation of hiPSC into NSC is achieved. By employing this solution, not only the differentiation of hiPSC into NSC is accelerated, but also long-term stable in-vitro passaging of NSC is achieved, so that donor cells are provided for the treatment of nervous system diseases, cell therapy, and the like, and the obtained NSC exosome has good biological activity.
TLX for use in the construction of human induced pluripotent stem cells (hiPSCs) that self-drivingly differentiate into neural stem cells (NSCs), wherein the TLX comprises at least one selected from the group consisting of the following I to IV:
(canceled)
A transcription unit, comprising a CMV promoter or an EFIA promoter, and a nucleic acid molecule the nucleic acid molecule comprising:
-16. (canceled)
A method for producing an exosome of neural stem cells (NSCs), comprising:
(canceled)
(canceled)
Dependencies are inferred from the claim text.